Back to AustralianSuper Pty Ltd AustralianSuper Pty Ltd

TEVATEVA

Showing 8 of 24 quarters

Position history for AustralianSuper Pty LtdAustralianSuper Pty Ltd's holdings in Teva Pharmaceutical Industries Limited

Yes. AustralianSuper holds 2,502,805 shares of TEVA (Teva Pharmaceutical Industries), worth $84.8M, as of its Q2 2026 13F filing. It reduced the position by 1,053,584 shares (-29.6%) from Q1 2026. AustralianSuper has held TEVA since Q3 2020, across 24 quarterly 13F filings. TEVA is 0.4% of AustralianSuper's reported 13F portfolio.

Current Value

$84.8M

Current Shares

2.5M

Total Value Change

-$57.4M

Total Shares Change

-5.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.5M
-29.6%
$84.8M0.4%$33.88
0
2026-Q1
Decreased
3.6M
-7.4%
$107.1M0.6%$30.12
0
2025-Q4
Decreased
3.8M
-22.6%
$119.9M0.6%$31.21
0
2025-Q3
Decreased
5M
-39.1%
$100.2M0.5%$20.20
0
2025-Q2
Decreased
8.2M
-4.8%
$136.6M0.7%$16.76
0
2025-Q1
Decreased
8.6M
-7.2%
$131.6M0.7%$15.37
0
2024-Q4
Increased
9.2M
+16.8%
$203.3M1.0%$22.04
50
2024-Q3
Decreased
7.9M
-7.2%
$142.2M0.7%$18.02
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used